Powered by evidence. Guided by expertise.
Executive Leadership Team
HERON Evidence Review Options
Pricing, Reimbursement, and Market Access Services
Global Pricing, Reimbursement and Market Access Services
Offshore/Onshore Evidence Development
Network of Expertise
Health Economics at HERON
Evidence Generation and Synthesis at HERON
Global Value Dossiers at HERON
HERON Evidence-to-Access Commercial Decision Support
Growth and Commercialization
HERON Growth and Commercialization Services
Evidence review, synthesis, and reporting
Health economic evaluation
Value messaging and dossier development
HERON Evidence-based Value Portfolio
ACCESS PLANNING & REALIZATION
Pricing, reimbursement, and market access program development
HERON Evidence-to-Access Commercial Decision Support™
PAREXEL International Announces Acquisition of HERON Group LTD, a Leading Commercialization Consultancy
PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced that today the Company acquired all of the outstanding equity securities of the HERON Group LTD (“HERON”), a life sciences consultancy which prov
HERON US to sponsor ‘Generating Evidence for Reimbursement Decisions: Therapeutics’, Nov. 5-6 2012, Philadelphia
HERON announces conference sponsorship for Philadelphia event.
HERON publishes cost-utility analysis of tiotropium versus usual care in UK/Belgian patients with COPD
HERON publishes paper on chronic obstructive pulmonary disease in British and Belgian patients.
ISPOR is about evidence and HERON is sending a strong signal
Your evidence should be a strong signal of value as well as a guide to informed decision making. Join the discussion at booth 62, ISPOR Berlin.
A new HERON publication: ‘The impact of specific HIV-treatment related adverse events on adherence to anti-retroviral therapy’
Drawing on years of experience in evidence-based medicine to guide strategic decision-making, a HERON team recently published the results of their research on adherence to HIV therapy
New UK health secretary appointed - the course of UK healthcare reform less than certain for Pharma
Jeremy Hunt replaces Andrew Lansley as Secretary of State for Health to take the reigns of the coalition government's controversial healthcare reforms.
HERON at ISPOR Washington
An overview of HERON's presence at ISPOR Washington, including finalist nomination details of HERON's conference posters.
New Look for the HERON Website
HERON are pleased to introduce a brand new website design.
ISPOR Attendees Generate UN Food Donation
HERON Food for Thought Presentation Attendees Spark Donation to UN World Food Programme
A HERON Webinar 6 October: “Including Commercially-Focused Endpoints in Clinical Trials: Process and Benefits”
HERON announces new webinar on commercially focussed endpoints in clinical trials, benefits and processes.
ISPOR Madrid: Attend a short presentation at HERON’s booth and a donation will be made on your behalf to the UN Food Program
HERON announce a series of talks at ISPOR Madrid in the HERON Food for Thought Series
HERON Webinars on CER and VBP available to view online
HERON recorded webinars on Comparative Effectiveness Research and Value Based Pricing available to view online.
© 2012 HERON Group or its affiliates. All rights reserved